Aarti Pharmalabs Limited (AARTIPHARM) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.022x

Based on the latest financial reports, Aarti Pharmalabs Limited (AARTIPHARM) has a cash flow conversion efficiency ratio of 0.022x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs362.80 Million ≈ $3.92 Million USD) by net assets (Rs16.58 Billion ≈ $179.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Aarti Pharmalabs Limited balance sheet quality to measure how much of total assets are equity-financed.

Aarti Pharmalabs Limited - Cash Flow Conversion Efficiency Trend (2020–2025)

This chart illustrates how Aarti Pharmalabs Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Aarti Pharmalabs Limited's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Aarti Pharmalabs Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aarti Pharmalabs Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Henan Tong-Da Cable Co Ltd SHE:002560	0.101x
Foosung KO:093370	-0.023x
Wecome Intelligent Manufacturing Co. Ltd. SHG:603070	N/A
Zhejiang Chunhui Intelligent Control Co. Ltd. SHE:300943	-0.001x
ITE Tech Inc TW:3014	0.062x
CK Power Public Company Limited BK:CKP	0.040x
Zhejiang Jihua Group Co Ltd SHG:603980	0.012x
ABBISKO CAYMAN DL-00001 F:8ZD	N/A

Annual Cash Flow Conversion Efficiency for Aarti Pharmalabs Limited (2020–2025)

The table below shows the annual cash flow conversion efficiency of Aarti Pharmalabs Limited from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Aarti Pharmalabs Limited worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs19.90 Billion ≈ $215.20 Million	Rs3.32 Billion ≈ $35.86 Million	0.167x	+35.32%
2024-03-31	Rs17.57 Billion ≈ $190.02 Million	Rs2.16 Billion ≈ $23.40 Million	0.123x	-27.03%
2023-03-31	Rs15.58 Billion ≈ $168.54 Million	Rs2.63 Billion ≈ $28.44 Million	0.169x	+635.36%
2022-03-31	Rs13.86 Billion ≈ $149.94 Million	Rs-437.04 Million ≈ $-4.73 Million	-0.032x	--
2021-03-31	Rs2.27 Million ≈ $24.52K	Rs0.00 ≈ $0.00	0.000x	--
2020-03-31	Rs2.31 Million ≈ $25.02K	Rs-186.75K ≈ $-2.02K	-0.081x	--

About Aarti Pharmalabs Limited

NSE:AARTIPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$654.02 Million

Rs60.48 Billion INR

Market Cap Rank

#10716 Global

#539 in India

Share Price

Rs667.15

Change (1 day)

-1.06%

52-Week Range

Rs591.95 - Rs939.50

All Time High

Rs964.90